The polymorphism of the ACE gene affects left ventricular hypertrophy and causes disturbances in left ventricular systolic/diastolic function in patients with autosomal dominant polycystic kidney disease.

PubWeight™: 0.75‹?›

🔗 View Article (PMC 3929983)

Published in ScientificWorldJournal on January 02, 2014

Authors

Maria Wanic-Kossowska1, Bartlomiej Posnik1, Mikolaj Kobelski1, Elzbieta Pawliczak1, Krzysztof Pawlaczyk1, Krzysztof Hoppe1, Krzysztof Schwermer1, Dorota Sikorska1

Author Affiliations

1: Department of Nephrology, Transplantology and Internal Medicine, Poznan University of Medical Sciences, 60-355 Poznan, Poland.

Articles cited by this

Prediction of creatinine clearance from serum creatinine. Nephron (1976) 64.02

Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr (2005) 46.32

Recommendations for chamber quantification. Eur J Echocardiogr (2006) 11.39

Evaluation of ultrasonographic diagnostic criteria for autosomal dominant polycystic kidney disease 1. Lancet (1994) 3.73

Autosomal dominant polycystic kidney disease--more than a renal disease. Am J Kidney Dis (1990) 1.53

Echocardiographic findings in autosomal dominant polycystic kidney disease. N Engl J Med (1988) 1.40

Modifier effect of ENOS in autosomal dominant polycystic kidney disease. Hum Mol Genet (2002) 1.20

Cardiovascular abnormalities associated with adult polycystic kidney disease. Ann Intern Med (1984) 1.16

Endothelial dysfunction and increased carotid intima-media thickness in patients with autosomal dominant polycystic kidney disease. Am J Kidney Dis (2004) 1.04

Cardiac disease in dialysis patients: diagnosis, burden of disease, prognosis, risk factors and management. Nephrol Dial Transplant (2000) 1.01

Comparison between siblings and twins supports a role for modifier genes in ADPKD. Kidney Int (2004) 0.96

Coronary flow velocity reserve and carotid intima media thickness in patients with autosomal dominant polycystic kidney disease: from impaired tubules to impaired carotid and coronary arteries. Clin J Am Soc Nephrol (2008) 0.94

Uraemic cardiomyopathy. Nephrol Dial Transplant (1998) 0.93

Polycystic kidney disease in 2011: Connecting the dots toward a polycystic kidney disease therapy. Nat Rev Nephrol (2011) 0.93

Association of the angiotensin I converting enzyme gene deletion polymorphism with early onset of ESRF in PKD1 adult polycystic kidney disease. Kidney Int (1997) 0.92

Influence of the ACE gene polymorphism in the progression of renal failure in autosomal dominant polycystic kidney disease. Am J Kidney Dis (1999) 0.91

Biventricular diastolic dysfunction in patients with autosomal-dominant polycystic kidney disease. Kidney Int (2005) 0.89

Effect of ACE gene polymorphism on age at renal death in polycystic kidney disease in Japan. Am J Kidney Dis (2001) 0.89

Exercise blood pressure, cardiac structure, and diastolic function in young normotensive patients with polycystic kidney disease: a prehypertensive state. Am J Kidney Dis (2004) 0.89

Reversal of left ventricular hypertrophy with angiotensin converting enzyme inhibition in hypertensive patients with autosomal dominant polycystic kidney disease. Nephrol Dial Transplant (1999) 0.87

Cardiac involvement in autosomal-dominant polycystic kidney disease: a hypertensive heart disease. Clin Nephrol (2001) 0.86

Left ventricular mass in normotensive subjects with autosomal dominant polycystic kidney disease. BMJ (1994) 0.85

Insulin resistance and coronary flow velocity reserve in patients with autosomal dominant polycystic kidney disease. Intern Med J (2012) 0.84

The ACE insertion/deletion polymorphism has no influence on progression of renal function loss in autosomal dominant polycystic kidney disease. Nephrol Dial Transplant (2000) 0.81

Angiotensin-converting enzyme activity and the ACE Alu polymorphism in autosomal dominant polycystic kidney disease. Nephrol Dial Transplant (2001) 0.80

Lack of association of ACE/angiotensinogen genotype with renal function in autosomal dominant polycystic kidney disease. Genet Test (2000) 0.80

Cardiovascular mortality of patients with polycystic kidney disease on dialysis: is there a lesson to learn? Nephron (1994) 0.80

Association of the ACE gene polymorphism with the progression of autosomal dominant polycystic kidney disease. J Korean Med Sci (2000) 0.79

Autosomal dominant polycystic kidney disease - clinical and genetic aspects. Kidney Blood Press Res (2002) 0.79

Vascular abnormalities in patients with autosomal dominant polycystic kidney disease--the influence on arteriovenous fistula creation. Clin Nephrol (2004) 0.77

Statistical analysis of medical data. Part II. J Nucl Cardiol (2000) 0.77

Association between angiotensin converting enzyme gene polymorphism and clinical features in autosomal dominant polycystic kidney disease. Life Sci (1997) 0.77

Influence of ACE (I/D) and G460W polymorphism of alpha-adducin in autosomal dominant polycystic kidney disease. Nephrol Dial Transplant (2003) 0.77

Statistical analysis of medical data. Part I: Univariable analysis. J Nucl Cardiol (2000) 0.76

Statistical analysis of medical data. Part III: multivariable analysis. J Nucl Cardiol (2001) 0.76

Cardiac valvular abnormalities in ADPKD. Preliminary results from the Italian Multicentric Study. Contrib Nephrol (1995) 0.76

[ADPKD patients on dialysis]. Nihon Rinsho (2004) 0.76